Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Use of bacteriophages in the treatment of Pseudomonas aeruginosa infections.

Soothill J.

Expert Rev Anti Infect Ther. 2013 Sep;11(9):909-15. doi: 10.1586/14787210.2013.826990. Review.

PMID:
24053272
2.

Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice.

Saussereau E, Debarbieux L.

Adv Virus Res. 2012;83:123-41. doi: 10.1016/B978-0-12-394438-2.00004-9. Review.

PMID:
22748810
3.

Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.

Alemayehu D, Casey PG, McAuliffe O, Guinane CM, Martin JG, Shanahan F, Coffey A, Ross RP, Hill C.

MBio. 2012 Mar 6;3(2):e00029-12. doi: 10.1128/mBio.00029-12. Print 2012.

4.

Isolation and characterization of two bacteriophages with strong in vitro antimicrobial activity against Pseudomonas aeruginosa isolated from dogs with ocular infections.

Santos TM, Ledbetter EC, Caixeta LS, Bicalho ML, Bicalho RC.

Am J Vet Res. 2011 Aug;72(8):1079-86. doi: 10.2460/ajvr.72.8.1079.

PMID:
21801066
5.

Bacteriophages for the treatment of Pseudomonas aeruginosa infections.

Harper DR, Enright MC.

J Appl Microbiol. 2011 Jul;111(1):1-7. doi: 10.1111/j.1365-2672.2011.05003.x. Epub 2011 Apr 18. Review.

6.

Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial.

Hawkins C, Harper D, Burch D, Anggård E, Soothill J.

Vet Microbiol. 2010 Dec 15;146(3-4):309-13. doi: 10.1016/j.vetmic.2010.05.014. Epub 2010 May 12.

PMID:
20627620
7.
8.

Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.

Krylov V, Shaburova O, Pleteneva E, Krylov S, Kaplan A, Burkaltseva M, Polygach O, Chesnokova E.

Virol Sin. 2015 Feb;30(1):33-44. doi: 10.1007/s12250-014-3546-3. Epub 2015 Feb 5.

PMID:
25680443
9.

Multiplication of therapeutically administered bacteriophages in Pseudomonas aeruginosa infected patients.

Marza JA, Soothill JS, Boydell P, Collyns TA.

Burns. 2006 Aug;32(5):644-6. Epub 2006 Jun 15. No abstract available.

PMID:
16781080
10.

Evaluation of biofilm production by Pseudomonas aeruginosa from canine ears and the impact of biofilm on antimicrobial susceptibility in vitro.

Pye CC, Yu AA, Weese JS.

Vet Dermatol. 2013 Aug;24(4):446-9, e98-9. doi: 10.1111/vde.12040. Epub 2013 Jun 5.

PMID:
23738965
11.

Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.

Vinodkumar CS, Kalsurmath S, Neelagund YF.

Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):360-6.

12.

Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection model.

Byrd MS, Pang B, Hong W, Waligora EA, Juneau RA, Armbruster CE, Weimer KE, Murrah K, Mann EE, Lu H, Sprinkle A, Parsek MR, Kock ND, Wozniak DJ, Swords WE.

Infect Immun. 2011 Aug;79(8):3087-95. doi: 10.1128/IAI.00057-11. Epub 2011 Jun 6.

13.

Characterization of JG024, a pseudomonas aeruginosa PB1-like broad host range phage under simulated infection conditions.

Garbe J, Wesche A, Bunk B, Kazmierczak M, Selezska K, Rohde C, Sikorski J, Rohde M, Jahn D, Schobert M.

BMC Microbiol. 2010 Nov 26;10:301. doi: 10.1186/1471-2180-10-301.

14.

Bacteriophage-based therapy in cystic fibrosis-associated Pseudomonas aeruginosa infections: rationale and current status.

Hraiech S, Brégeon F, Rolain JM.

Drug Des Devel Ther. 2015 Jul 16;9:3653-63. doi: 10.2147/DDDT.S53123. eCollection 2015. Review.

15.

Antibacterial efficacy of phages against Pseudomonas aeruginosa infections in mice and Drosophila melanogaster.

Heo YJ, Lee YR, Jung HH, Lee J, Ko G, Cho YH.

Antimicrob Agents Chemother. 2009 Jun;53(6):2469-74. doi: 10.1128/AAC.01646-08. Epub 2009 Apr 13.

16.

A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.

Wright A, Hawkins CH, Anggård EE, Harper DR.

Clin Otolaryngol. 2009 Aug;34(4):349-57. doi: 10.1111/j.1749-4486.2009.01973.x.

PMID:
19673983
17.

Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.

Krylov VN.

Adv Virus Res. 2014;88:227-78. doi: 10.1016/B978-0-12-800098-4.00005-2. Review.

PMID:
24373314
18.

Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.

Wang J, Hu B, Xu M, Yan Q, Liu S, Zhu X, Sun Z, Reed E, Ding L, Gong J, Li QQ, Hu J.

Int J Mol Med. 2006 Feb;17(2):309-17.

PMID:
16391831
19.

Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.

Teresa Tejedor M, Martín JL, Navia M, Freixes J, Vila J.

Vet Microbiol. 2003 Jul 30;94(4):295-301.

PMID:
12829383
20.

[Phagotherapy: a nightmare for bacteria, a dream for physicians?].

Debarbieux L, Saussereau E, Maura D.

Biol Aujourdhui. 2013;207(3):181-90. doi: 10.1051/jbio/2013017. Epub 2013 Dec 13. Review. French.

PMID:
24330971
Items per page

Supplemental Content

Write to the Help Desk